Abstract:Purpose: Artemis and DNA Ligase IV are 2 critical elements in the nonhomologous end joining pathway of DNA repair, acting as the nuclease and DNA ligase, respectively. Enhanced cellular radiosensitivity by inhibition of either protein contributes to a promising approach to develop molecular targeted radiosensitizers. The interaction between Artemis and DNA Ligase IV is required for the activation of Artemis as nuclease at 3'overhang DNA; thus, we aim to generate an inhibitory peptide targeting the interaction between Artemis and DNA Ligase IV for novel radiosensitizer development. Methods and Materials: We synthesized the peptide BAL, which consists of the interaction residues of Artemis to DNA Ligase IV. The radiosensitization effect of BAL was evaluated by colony formation assay. The effects of BAL on radiation induced DNA repair were evaluated with Western blotting and immunofluorescence. The effects of BAL on cell proliferation, cell cycle arrest, and cell apoptosis were assessed via CCK-8 and flow cytometry assays. The potential synergistic effects of BAL and irradiation in vivo were investigated in a xenograft mouse model. Results: The generated peptide BAL blocking the interaction between Artemis and DNA Ligase IV significantly enhanced the radiosensitivity of GBC-SD and HeLa cell lines. BAL prolonged DNA repair after irradiation; BAL and irradiation showed synergistic effects on cell proliferation, cell cycle, and cell apoptosis, and these functions are all DNA Ligase IV-related. Finally, we confirmed the endogenous radiosensitization effect of BAL in a xenograft mouse model. Conclusions: The inhibitory peptide BAL targeting the binding of Artemis and DNA Ligase IV successfully functions as a novel radiosensitizer that delays DNA repair and synergizes with irradiation to inhibit cell proliferation, induce cell cycle arrest, and promote cell apoptosis. (C) 2021 Elsevier Inc. All rights reserved.

Rational Design Of Human Dna Ligase Inhibitors That Target Cellular Dna Replication And Repair

Data from Rational Design of Human DNA Ligase Inhibitors that Target Cellular DNA Replication and Repair

Identification And Validation Of Human Dna Ligase Inhibitors Using Computer-Aided Drug Design

Developing a Peptide That Inhibits DNA Repair by Blocking the Binding of Artemis and DNA Ligase IV to Enhance Tumor Radiosensitivity.

Supplementary Figure 5 from Rational Design of Human DNA Ligase Inhibitors That Target Cellular DNA Replication and Repair

Structures of DNA-bound human ligase IV catalytic core reveal insights into substrate binding and catalysis

Structure and Mechanism of Human DNA Polymerase Η

Molecular Cloning and Expression of Human Cdnas Encoding a Novel DNA Ligase IV and DNA Ligase III, an Enzyme Active in DNA Repair and Recombination.

Biochemical, structural, and single-molecule characterization of LIG1 active site mutants demonstrate role of F635 and F872 residues for faithful ligation

Impact of DNA ligase inhibition on the nick sealing of polβ nucleotide insertion products at the downstream steps of base excision repair pathway

Identification Through Structure-Based Methods of a Bacterial NAD(+)-dependent DNA Ligase Inhibitor That Avoids Known Resistance Mutations.

Biochemical Characterization of Two DNA Ligases from Deinococcus Radiodurans.

Drug Design for XRCC4 in Silico

Human DNA ligases I and III have stand-alone end-joining capability, but differ in ligation efficiency and specificity

3D-QSAR Studies on a Series of Inhibitors Docked into a New Homology Model of the DNA-PK Receptor.

Identification through structure-based methods of a bacterial NAD(+)-dependent DNA ligase inhibitor that avoids known resistance mutations(vol 24, pg 360, 2014)

Novel Bacterial NAD + -Dependent DNA Ligase Inhibitors with Broad-Spectrum Activity and Antibacterial Efficacy in Vivo

Human DNA ligase IV is able to use NAD+ as an alternative adenylation donor for DNA ends ligation

A Direct Approach Toward Investigating DNA-ligand Interactions Via Surface-Enhanced Raman Spectroscopy Combined with Molecular Dynamics Simulations.

Solution Structure and DNA Binding of the Zinc-finger Domain from DNA Ligase IIIα

Synthesis and Biological Research of Novel Azaacridine Derivatives As Potent DNA-binding Ligands and Topoisomerase II Inhibitors